Clinical Trials
7 trialsNCT06019468 2026-05-08
Neoadjuvant Treatment For Locally Advanced Thymic Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2 Recruiting
NCT07571525 2026-05-06
TAILOR-MG
IRCCS San Raffaele
Not yet recruiting
NCT02633514 2026-04-27
Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma
Fudan University
Phase 3 Withdrawn
NCT06402708 2026-04-27
Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)
Fudan University
Phase 3 Recruiting
NCT02633553 2026-04-24
Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection
Fudan University
Phase NA Recruiting
NCT03463460 2026-03-23
Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer
Ohio State University Comprehensive Cancer Center
Phase 2 Active not recruiting
NCT07479628 2026-03-18
Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma
Shanghai Chest Hospital
Phase 2 Not yet recruiting